A Study of Golimumab in the Treatment of Indian Participants With Active Spondyloarthropathy of Ankylosing Spondylitis or Psoriatic Arthritis

NCT03733925 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

100

Enrollment

INDUSTRY

Sponsor class

Conditions

Spondylitis, Ankylosing
Arthritis, Psoriatic

Interventions

DRUG: Golimumab

Sponsor

Johnson & Johnson Private Limited